- Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Larsen, C.P., Pearson, T.C., Adams, A.B., Tso, P., Shirasugi, N., Strobertm, E., Anderson, D., Cowan, S., Price, K., Naemura, J., Emswiler, J., Greene, J., Turk, L.A., Bajorath, J., Townsend, R., Hagerty, D., Linsley, P.S., Peach, R.J. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. (2005)